Table of Content

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kit Manufacturing Facilities
4.2.5. Analysis by Certifications / Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Kit Components
4.2.10. Analysis by Storage Temperature
4.2.11. Analysis by Scale of Operation
4.2.12. Analysis by Application Area
4.2.13. Analysis by Application Area and Geography
4.3. List of Cell Therapy Media Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Manufacturing Facilities
4.3.5. Analysis by Certifications / Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Compatibility
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Storage Temperature
4.3.11. Analysis by Volume of Media
4.3.12. Analysis by Scale of Operation
4.3.13. Analysis by Application Area
4.3.14. Analysis by Application Area and Geography
4.4. List of Cell Therapy Reagent Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Manufacturing Facilities
4.4.5. Analysis by Certifications / Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Storage Temperature
4.4.10. Analysis by Volume of Reagent
4.4.11. Analysis by Scale of Operation
4.4.12. Analysis by Application Area
4.4.13. Analysis by Application Area and Geography
4.5. List of Cell Therapy Extracellular Matrix Providers
4.5.1. Analysis by Year of Establishment
4.5.2. Analysis by Company Size
4.5.3. Analysis by Location of Headquarters
4.5.4. Analysis by Location of Extracellular Matrix Manufacturing Facilities
4.5.5. Analysis by Certifications / Accreditations Received
4.5.6. Analysis by Type of End-User
4.5.7. Analysis by Type of Stem Cell Therapy
4.5.8. Analysis by Type of Function
4.5.9. Analysis by Type of ECM Coating
4.5.10. Analysis by Type of Formulation
4.5.11. Analysis by Shelf Life
4.5.12. Analysis by Storage Temperature
4.5.13. Analysis by Volume of Extracellular Matrix
4.5.14. Analysis by Scale of Operation
4.5.15. Analysis by Application Area
4.5.16. Analysis by Application Area and Geography

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumable Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.6.1. Cell Therapy Media Providers based in North America
5.6.2. Cell Therapy Media Providers based in Europe
5.6.3. Cell Therapy Media Providers based in Asia-Pacific
5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Miltenyi Biotec
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Thermo Fisher Scientific
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Bio-Techne
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Irvine Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
7.7. Lonza
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook
7.8. Sartorius
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook
7.9. BD Biosciences
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook
7.10. Corning
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook
7.11. CellGenix
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook

8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Cell Therapy
8.3.7. Analysis by Type of Product and Type of Cell Therapy
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Region
8.3.9.1. Intercontinental and Intracontinental Agreements
8.3.9.2. Local and International Agreements
8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.4.1. Cumulative Year-wise Trend of Mergers and Acquisitions
8.4.2. Analysis by Type of Agreement
8.4.3. Analysis by Key Value Drivers
8.4.4. Analysis by Year of Acquisition and Key Value Drivers
8.5. Cell Therapy Consumables: Recent Expansions
8.5.1. Analysis by Year of Expansion
8.5.2. Analysis by Type of Expansion
8.5.3. Analysis by Year and Type of Expansion
8.5.4. Analysis by Type of Product
8.5.5. Analysis by Type of Expansion and Type of Product
8.5.6. Analysis by Area of Expansion
8.5.7. Most Active Players: Analysis by Number of Expansions
8.5.8. Analysis by Region
8.5.8.1. Analysis by Location of Facility (Continent-wise)
8.5.8.2. Analysis by Location of Facility (Country-wise)
8.5.9. Analysis by Type of Expansion and Location of Facility
9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.4.1. Likely Partners for Dendritic Cell Therapy Consumable Providers
9.4.2. Likely Partners for NK Cell Therapy Consumable Providers
9.4.3. Likely Partners for Stem Cell Therapy Consumable Providers
9.4.4. Likely Partners for T-Cell Therapy Consumable Providers
10. ROOTS ANALYSIS PRICING STRATEGY
10.1. Chapter Overview
10.2. Roots Analysis Framework
10.2.1. Theoretical Framework and Price Evaluation Hypothesis for Cell Therapy Media
10.2.1.1. Methodology
10.2.1.2. Results and Interpretation
10.2.1.2.1. Cell Therapy Media Price Evaluation Matrix: Information on Volume of Media
10.2.1.2.2. Cell Therapy Media Price Evaluation Matrix: Information on Media Compatibility
10.2.1.2.3. Cell Therapy Media Price Evaluation Matrix: Information on Type of Product Manufacturing Practices
10.2.1.2.4. Cell Therapy Media Price Evaluation Matrix: Information on Application Area
10.2.1.2.5. Cell Therapy Media Price Evaluation Matrix: Information on Storage Temperature
10.2.1.2.6. Cell Therapy Media Price Evaluation Matrix: Information on Type of Cell Therapy
10.2.1.2.7. Cell Therapy Media Price Evaluation Matrix: Information on Type of Function
10.2.2. Theoretical Framework and Price Evaluation Hypothesis of Cell Therapy Extracellular Matrices
10.2.2.1. Methodology
10.2.2.2. Results and Interpretation
10.2.2.2.1. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of ECM Coating
10.2.2.2.2. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Formulation
10.2.2.2.3. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Volume of Extracellular Matrices
10.2.2.2.4. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Storage Temperature
10.2.2.2.5. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Shelf Life
10.2.2.2.6. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Stem Cell Therapy
10.2.2.2.7. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Function

11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.3.1. Global Demand for Cell Therapy Consumables for Planar Processes
11.3.2. Global Demand for Cell Therapy Consumables for Suspension Processes
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, 2023-2035
12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.4.1. Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035
12.4.2. Cell Therapy Consumables Market for Kits, 2023-2035
12.4.3. Cell Therapy Consumables Market for Media, 2023-2035
12.4.4. Cell Therapy Consumables Market for Reagents, 2023-2035
12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.5.1. Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035
12.5.2. Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035
12.5.3. Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035
12.5.4. Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035
12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.6.1. Cell Therapy Consumables Market for Clinical Operations, 2023-2035
12.6.2. Cell Therapy Consumables Market for Commercial Operations, 2023-2035
12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.7.1. Cell Therapy Consumables Market for Industry Players, 2023-2035
12.7.2. Cell Therapy Consumables Market for Non-Industry Players, 2023-2035
12.8. Cell Therapy Consumables Market: Analysis by Geography
12.8.1. Cell Therapy Consumables Market in North America, 2023-2035
12.8.1.1. Cell Therapy Consumables Market in the US, 2023-2035
12.8.1.2. Cell Therapy Consumables Market in Canada, 2023-2035
12.8.1.3. Cell Therapy Consumables Market in Rest of North America, 2023-2035
12.8.2. Cell Therapy Consumables Market in Europe, 2023-2035
12.8.2.1. Cell Therapy Consumables Market in Spain, 2023-2035
12.8.2.2. Cell Therapy Consumables Market in France, 2023-2035
12.8.2.3. Cell Therapy Consumables Market in Germany, 2023-2035
12.8.2.4. Cell Therapy Consumables Market in Italy, 2023-2035
12.8.2.5. Cell Therapy Consumables Market in the Netherlands, 2023-2035
12.8.2.6. Cell Therapy Consumables Market in the UK, 2023-2035
12.8.2.7. Cell Therapy Consumables Market in Rest of Europe, 2023-2035
12.8.3. Cell Therapy Consumables Market in Asia-Pacific, 2023-2035
12.8.3.1. Cell Therapy Consumables Market in China, 2023-2035
12.8.3.2. Cell Therapy Consumables Market in Korea, 2023-2035
12.8.3.3. Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035
12.8.4. Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035
12.8.5. Cell Therapy Consumables Market in Latin America, 2023-2035

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing

14. CONCLUDING REMARKS

15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Akadeum Life Sciences
15.2.1. Interview Transcript: Michael Maloney, Vice President of Business Development - Cell Therapy
15.3. Cellular Engineering Technologies
15.3.1. Interview Transcript: Anant Kamath, Chief Operating Officer
15.4. HiMedia Laboratories
15.4.1. Interview Transcript: Vishal G. Warke, Director R&D, Cell Culture and Immunology and Gauri W. Page, Assistant R&D Manager, Animal Cell Culture

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS